Brian Schulte

Dr. Brian Schulte is a physician-scientist at the University of California San Francisco (UCSF), specializing in sarcomas — rare cancers arising from connective tissues. His clinical work focuses on multidisciplinary care for sarcoma patients, while his research explores novel medications (single and combination therapies) and the application of artificial intelligence in oncology. He received formal training in internal medicine and hematology-oncology, with a bachelor's degree in biomedical engineering and a medical degree.

Education
• BSE in Biomedical Engineering, Duke University (2009)
• MD from Medical College of Wisconsin (2015)
• Internal Medicine Residency, University of Colorado Anschutz Medical Campus (2018)
• Hematology-Oncology Fellowship, Northwestern University Feinberg School of Medicine (2021)
• Diversity, Equity, and Inclusion Champion Training, University of California (2021)

Dr. Schulte’s research spans sarcoma pharmacology (e.g., FDA-approved drug trends), immunotherapy (e.g., PD-1 inhibition, CAR T-cells), and AI applications in treatment guideline adherence. Recent publications highlight his work on targeted therapies, chemotherapy regimens, and tumor microenvironment dynamics.

Notable awards include the Sarcoma Immunotherapy Initiative Clinical Champion at UCSF (2023-pres), Chief Fellow at Northwestern University (2019-2020), and induction into Alpha Omega Alpha (2014). His work appears in journals like Cancer, JAMA Oncology, and Frontiers in Oncology, covering topics from drug pricing to AI in clinical decision-making.